3 patents
Utility
Use of DKK-1 Inhibitors for Treating Cancer
1 Dec 22
A method of treating a cancer in a subject, in need thereof, comprising determining a DKK1 expression H-score or % positive in a sample of the subject's cancer; and administering a DKK1 antagonist to the subject determined to have the DKK1 expression H-score or % positive equal to or greater than a predetermined value.
Michael H. Kagey, Girish Somaia Naik, Cynthia A. Sirard
Filed: 18 Sep 20
Utility
Use of Beta-catenin As a Biomarker for Treating Cancers Using ANTI-DKK-1 Antibody
15 Sep 22
A method of treating a cancer in a subject in need thereof is disclosed.
Michael H. Kagey, Cynthia A. Sirard
Filed: 28 Jan 22
Utility
Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibody
8 Mar 22
A method of treating a cancer in a subject in need thereof is disclosed.
Michael H. Kagey, Cynthia A. Sirard
Filed: 26 Oct 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first